GSK and AstraZeneca are seeking FDA approval for new specialty medicines amid market competition.

The entities involved

• GSK →

  British multinational pharmaceutical and biotechnology company

  • Uncertainty over a dispute involving GSK and AnaptysBio weighed on market sentiment.Sat 23:22
  • FDA approved a GSK drug and authorized a Roche blood test for eligibility, amidst estimates of 1.7M chronic HBV patients in the US.Fri 12:54
• AstraZeneca →

  British-Swedish pharmaceutical company

  • Mario Lopez promoted AstraZeneca's cancer testing campaign, while Dennis Haskins was noted for treating young stars with respect.Sat 23:05
  • European stock markets showed mixed performance on October 30, with some sectors rising while tech faced sell-off concerns.Fri 20:53
• FDA →
  • NRx Pharmaceuticals is seeking regulatory approval from the FDA for its drug candidates, NRX-100 and NRX-101.00:24
  • A couple in Newfane, NY, faces drug oversight issues while Lucas is in Niagara County rehab.Sat 17:28

Related events

• Generic medicine services are seeking approval for launch from the FDA.Sep 28
• Cardiff Oncology and Nerviano Medical Sciences are seeking FDA regulatory review for Phase 3 trials and managing a licensing dispute over onvansertib.Jun 30
• FDA approved a new cancer drug in Massachusetts on October 21, 2026.Oct 22
• Merck announced on September 3, 2025, that it is seeking potential approval for new drugs from the FDA.Jun 7
• FDA approval expands patient access to therapies for ACCORD.Jul 10